ZERIT XR Detail

Drug Name(s):
ZERIT XR

FDA Application No.:
NDA 021453

Active Ingredient(s):
STAVUDINE

Company:
BRISTOL MYERS SQUIBB

Original Approval or Tentative Approval Date:
June 3, 2004

Products on Application NDA 021453:

Active Ingredients	Strenght	Dosage Form	Marketing Status	TE Code
STAVUDINE	100MG	CAPSULE, EXTENDED RELEASE; ORAL	Discontinued	none
STAVUDINE	50MG	CAPSULE, EXTENDED RELEASE; ORAL	Discontinued	none

Welcome

Did you know it can take decades for medical innovations to be widely adopted by the healthcare community? To make the best decisions for your health, you need more information than your physician alone can provide. Medicine.org is here to help you become an advocate for your own health by allowing you to share and discover the current healthcare information you need. Learn more.

Navigation

Resources

Medical Dictionary

Drug Information

Events

«	November 2008
S	M	T	W	T	F	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30

Who's online

There are currently 0 users and 473 guests online.

Medicine.org is an online community where consumers can share health resources and information. It is intended to supplement, not replace, professional medical care. Always consult your doctor for medical advice related to your specific health condition.

About | Privacy Statement | Terms & Conditions | Contact Us | Link Resources

HONcode accreditation seal.

We comply with the HONcode standard for health trust worthy information:
verify here.

last updated on 11-21-2008

Links to Site